Status:
COMPLETED
Development and Pilot Testing of a PHCI for Emergency Department Patients Who Decline Rapid HIV/ HCV Screening
Lead Sponsor:
Rhode Island Hospital
Conditions:
Hiv
Hepatitis C
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
The Centers for Disease Control and Prevention (CDC) recommends that emergency departments (EDs) and other health care facilities conduct HIV and HCV screening to identify and link to care those with ...
Detailed Description
The investigators will conduct this R34 project at the Rhode Island Hospital ED, the primary site for many of the research team's previous HIV (Human Immunodeficiency Virus) and HCV (Hepatitis C Virus...
Eligibility Criteria
Inclusion
- 18-64 years old
- English or Spanish speaking
Exclusion
- HIV positive; HCV positive In an HIV vaccine trial
- On HIV pre-exposure prophylaxis medication
- In an HIV or HCV testing study
- Tested for HIV AND HCV within the past year (per EMR(Electronic Medical Record) review and patient report)
Key Trial Info
Start Date :
October 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04137094
Start Date
October 16 2019
End Date
January 1 2021
Last Update
August 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rhode Island Hospital
Providence, Rhode Island, United States, 02907